Activation of axonal Kv7 channels in human peripheral nerve by flupirtine but not placebo - therapeutic potential for peripheral neuropathies: results of a randomised controlled trial
Johannes Fleckenstein, Ruth Sittl, Beate Averbeck, Philip M Lang, Dominik Irnich, Richard W Carr, Johannes Fleckenstein, Ruth Sittl, Beate Averbeck, Philip M Lang, Dominik Irnich, Richard W Carr
Abstract
Background: Flupirtine is an analgesic with muscle-relaxing properties that activates Kv7 potassium channels. Kv7 channels are expressed along myelinated and unmyelinated peripheral axons where their activation is expected to reduce axonal excitability and potentially contribute to flupirtine's clinical profile.
Trial design: To investigate the electrical excitability of peripheral myelinated axons following orally administered flupirtine, in-vitro experiments on isolated peripheral nerve segments were combined with a randomised, double-blind, placebo-controlled, phase I clinical trial (RCT).
Methods: Threshold tracking was used to assess the electrical excitability of myelinated axons in isolated segments of human sural nerve in vitro and motoneurones to abductor pollicis brevis (APB) in situ in healthy subjects. In addition, the effect of flupirtine on ectopic action potential generation in myelinated axons was examined using ischemia of the lower arm.
Results: Flupirtine (3-30 μM) shortened the relative refractory period and increased post-conditioned superexcitability in human myelinated axons in vitro. Similarly, in healthy subjects the relative refractory period of motoneurones to APB was reduced 2 hours after oral flupirtine but not following placebo. Whether this effect was due to a direct action of flupirtine on peripheral axons or temperature could not be resolved. Flupirtine (200 mg p.o.) also reduced ectopic axonal activity induced by 10 minutes of lower arm ischemia. In particular, high frequency (ca. 200 Hz) components of EMG were reduced in the post-ischemic period. Finally, visual analogue scale ratings of sensations perceived during the post-ischemic period were reduced following flupirtine (200 mg p.o.).
Conclusions: Clinical doses of flupirtine reduce the excitability of peripheral myelinated axons.
Trial registration: ClinicalTrials registration is NCT01450865.
Figures
References
- Priestley T, Hunter JC. Voltage-gated sodium channels as molecular targets for neuropathic pain. Drug Dev Res. 2006;67:360–375. doi: 10.1002/ddr.20100.
- Miceli F, Soldovieri MV, Martire M, Taglialatela M. Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs. Curr Opin Pharmacol. 2008;8:65–74. doi: 10.1016/j.coph.2007.10.003.
- Hadley JK, Passmore GM, Tatulian L, Al-Qatari M, Ye F, Wickenden AD, Brown DA. Stoichiometry of expressed KCNQ2/KCNQ3 potassium channels and subunit composition of native ganglionic M channels deduced from block by tetraethylammonium. J Neurosci. 2003;23:5012–5019.
- Wang HS, Pan Z, Shi W, Brown BS, Wymore RS, Cohen IS, Dixon JE, McKinnon D. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science. 1998;282:1890–1893.
- Hernandez CC, Zaika O, Tolstykh GP, Shapiro MS. Regulation of neural KCNQ channels: signalling pathways, structural motifs and functional implications. J Physiol. 2008;586:1811–1821. doi: 10.1113/jphysiol.2007.148304.
- Schwarz JR, Glassmeier G, Cooper EC, Kao TC, Nodera H, Tabuena D, Kaji R, Bostock H. KCNQ channels mediate IKs, a slow K+ current regulating excitability in the rat node of Ranvier. J Physiol. 2006;573:17–34. doi: 10.1113/jphysiol.2006.106815.
- Dedek K, Kunath B, Kananura C, Reuner U, Jentsch TJ, Steinlein OK. Myokymia and neonatal epilepsy caused by a mutation in the voltage sensor of the KCNQ2 K+ channel. Proc Natl Acad Sci USA. 2001;98:12272–12277. doi: 10.1073/pnas.211431298.
- Devaux JJ, Kleopa KA, Cooper EC, Scherer SS. KCNQ2 is a nodal K+ channel. J Neurosci. 2004;24:1236–1244. doi: 10.1523/JNEUROSCI.4512-03.2004.
- Passmore GM, Selyanko AA, Mistry M, Al-Qatari M, Marsh SJ, Matthews EA, Dickenson AH, Brown TA, Burbidge SA, Main M, Brown DA. KCNQ/M currents in sensory neurons: significance for pain therapy. J Neurosci. 2003;23:7227–7236.
- Wladyka CL, Kunze DL. KCNQ/M-currents contribute to the resting membrane potential in rat visceral sensory neurons. J Physiol. 2006;575:175–189. doi: 10.1113/jphysiol.2006.113308.
- Wladyka CL, Feng B, Glazebrook PA, Schild JH, Kunze DL. The KCNQ/M-current modulates arterial baroreceptor function at the sensory terminal in rats. J Physiol. 2008;586:795–802.
- Lang PM, Fleckenstein J, Passmore GM, Brown DA, Grafe P. Retigabine reduces the excitability of unmyelinated peripheral human axons. Neuropharmacology. 2008;54:1271–1278. doi: 10.1016/j.neuropharm.2008.04.006.
- Sittl R, Carr RW, Fleckenstein J, Grafe P. Enhancement of axonal potassium conductance reduces nerve hyperexcitability in an in vitro model of oxaliplatin-induced acute neuropathy. Neurotoxicology. 2010;31:694–700. doi: 10.1016/j.neuro.2010.07.006.
- Biervert C, Schroeder BC, Kubisch C, Berkovic SF, Propping P, Jentsch TJ, Steinlein OK. A potassium channel mutation in neonatal human epilepsy. Science. 1998;279:403–406. doi: 10.1126/science.279.5349.403.
- Auger RG, Daube JR, Gomez MR, Lambert EH. Hereditary form of sustained muscle activity of peripheral nerve origin causing generalized myokymia and muscle stiffness. Ann Neurol. 1984;15:13–21. doi: 10.1002/ana.410150104.
- Gancher ST, Nutt JG. Autosomal dominant episodic ataxia; a heterogeneous syndrome. Mov Dis. 1986;1:239–253. doi: 10.1002/mds.870010404.
- Wuttke TV, Jurkat-Rott K, Paulus W, Garncarek M, Lehmann-Horn F, Lerche H. Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations. Neurology. 2007;69:2045–2053. doi: 10.1212/01.wnl.0000275523.95103.36.
- Castaldo P, del Giudice EM, Coppola G, Pascotto A, Annunziato L, Taglialatela M. Benign familial neonatal convulsions caused by altered gating of KCNQ2/KCNQ3 potassium channels. J Neurosci. 2002;22:RC199.
- Pongs O, Schwarz JR. Ancillary subunits associated with voltage-dependent K+ channels. Physiol Rev. 2010;90:755–796. doi: 10.1152/physrev.00020.2009.
- Cooper EC, Harrington E, Jan YN, Jan LY. M channel KCNQ2 subunits are localized to key sites for control of neuronal network oscillations and synchronization in mouse brain. J Neurosci. 2001;21:9529–9540.
- Singh NA, Charlier C, Stauffer D, DuPont BR, Leach RJ, Melis R, Ronen GM, Bjerre I, Quattlebaum T, Murphy JV. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat Genet. 1998;18:25–29. doi: 10.1038/ng0198-25.
- Pan Z, Selyanko AA, Hadley JK, Brown DA, Dixon JE, McKinnon D. Alternative splicing of KCNQ2 potassium channel transcripts contributes to the functional diversity of M-currents. J Physiol. 2001;531:347–358. doi: 10.1111/j.1469-7793.2001.0347i.x.
- Bostock H, Baker M, Reid G. Changes in excitability of human motor axons underlying post-ischaemic fasciculations: evidence for two stable states. J Physiol. 1991;441:537–557.
- Melzack R. The short-form McGill Pain Questionnaire. Pain. 1987;30:191–197. doi: 10.1016/0304-3959(87)91074-8.
- Lang PM, Grafe P. Chemosensitivity of unmyelinated axons in isolated human gastric vagus nerve. Auton Neurosci. 2007;136:100–104. doi: 10.1016/j.autneu.2007.05.001.
- Carr RW, Sittl R, Fleckenstein J, Grafe P. GABA increases electrical excitability in a subset of human unmyelinated peripheral axons. PLoS One. 2010;5:e8780. doi: 10.1371/journal.pone.0008780.
- Rose K, Ooi L, Dalle C, Robertson B, Wood IC, Gamper N. Transcriptional repression of the M channel subunit Kv7.2 in chronic nerve injury. Pain. 2011;152:742–754. doi: 10.1016/j.pain.2010.12.028.
- Roza C, Lopez-Garcia JA. Retigabine, the specific KCNQ channel opener, blocks ectopic discharges in axotomized sensory fibres. Pain. 2008;138:537–545. doi: 10.1016/j.pain.2008.01.031.
- Martire M, Castaldo P, D'Amico M, Preziosi P, Annunziato L, Taglialatela M. M channels containing KCNQ2 subunits modulate norepinephrine, aspartate, and GABA release from hippocampal nerve terminals. J Neurosci. 2004;24:592–597. doi: 10.1523/JNEUROSCI.3143-03.2004.
- Hlavica P, Niebch G. Pharmacokinetics and biotransformation of the analgesic flupirtine in humans. Arzneimittelforschung. 1985;35:67–74.
- Niebch G, Borbe HO, Hummel T, Kobal G. Dose-proportional plasma levels of the analgesic flupirtine maleate in man. Application of a new HPLC assay. Arzneimittelforschung. 1992;42:1343–1345.
- Hummel T, Friedmann T, Pauli E, Niebch G, Borbe HO, Kobal G. Dose-related analgesic effects of flupirtine. Br J Clin Pharmacol. 1991;32:69–76. doi: 10.1111/j.1365-2125.1991.tb05615.x.
- Maurer K, Wacker J, Vastani N, Seifert B, Spahn DR. Changes in axonal excitability of primary sensory afferents with general anaesthesia in humans. Br J Anaesth. 2010;105:648–656. doi: 10.1093/bja/aeq218.
- Yeung S, Schwake M, Pucovsky V, Greenwood I. Bimodal effects of the Kv7 channel activator retigabine on vascular K+ currents. Br J Pharmacol. 2008;155:62–72. doi: 10.1038/bjp.2008.231.
- Zaika O, Lara LS, Gamper N, Hilgemann DW, Jaffe DB, Shapiro MS. Angiotensin II regulates neuronal excitability via phosphatidylinositol 4,5-bisphosphate-dependent modulation of Kv7 (M-type) K+ channels. J Physiol. 2006;575:49–67. doi: 10.1113/jphysiol.2006.114074.
- Timmann D, Plummer C, Schwarz M, Diener HC. Influence of flupirtine on human lower limb reflexes. Electroencephalogr Clin Neurophysiol. 1995;97:184–188. doi: 10.1016/0924-980X(95)00049-Q.
- Klinger F, Geier P, Dorostkar MM, Chandaka GK, Yousuf A, Salzer I, Kubista H, Boehm S. Concomitant facilitation of GABAA receptors and KV7 channels by the non-opioid analgesic flupirtine. Br J Pharmacol. 2012;166:1631–1642. doi: 10.1111/j.1476-5381.2011.01821.x.
- Lin CS, Mogyoros I, Burke D. Recovery of excitability of cutaneous afferents in the median and sural nerves following activity. Muscle Nerve. 2000;23:763–770. doi: 10.1002/(SICI)1097-4598(200005)23:5<763::AID-MUS14>;2-D.
- Weddell G, Sinclair DC. Pins and needles; observations on some of the sensations aroused in a limb by the application of pressure. J Neurol Neurosurg Psychiatry. 1947;10:26–46. doi: 10.1136/jnnp.10.1.26.
- Merrington WR, Nathan PW. A study of post-ischaemic paraesthesiae. J Neurol Neurosurg Psychiatry. 1949;12:1–18. doi: 10.1136/jnnp.12.1.1.
- Ochoa JL, Torebjork HE. Paraesthesiae from ectopic impulse generation in human sensory nerves. Brain. 1980;103:835–853. doi: 10.1093/brain/103.4.835.
- Culp WJ, Ochoa JL, Torebjörk HE. In: Abnormal nerves and muscles as impulse generators. Culp WJ, Ochoa JL, editor. New York: Oxford University Press; 1982. Ectopic impulse generation in myelinted sensory nerve fibres in man; pp. 490–512.
- Bostock H, Rothwell JC. Latent addition in motor and sensory fibres of human peripheral nerve. J Physiol. 1997;498(Pt 1):277–294.
- Bostock H, Burke D, Hales JP. Differences in behaviour of sensory and motor axons following release of ischaemia. Brain. 1994;117(Pt 2):225–234.
- Yue C, Yaari Y. KCNQ/M channels control spike afterdepolarization and burst generation in hippocampal neurons. J Neurosci. 2004;24:4614–4624. doi: 10.1523/JNEUROSCI.0765-04.2004.
Source: PubMed